Lipid oligonucleotide conjugates as responsive nanomaterials for drug delivery

被引:36
|
作者
Pokholenko, Oleksandr [1 ,2 ]
Gissot, Arnaud [1 ,2 ]
Vialet, Brune [1 ,2 ]
Bathany, Katell [3 ]
Thiery, Alain [4 ]
Barthelemy, Philippe [1 ,2 ]
机构
[1] Univ Bordeaux Segalen, F-33076 Bordeaux, France
[2] INSERM, U869, F-33076 Bordeaux, France
[3] Univ Bordeaux, CBMN UMR 5248, F-33600 Pessac, France
[4] Aix Marseille Univ, UMR CNRS IMBE 7263, Marseille, France
关键词
NUCLEIC-ACIDS; DNA; MICELLES; AMPHIPHILES; MEMBRANES; HYBRID; HYBRIDIZATION; NANOCARRIERS; ASSEMBLIES; COPOLYMERS;
D O I
10.1039/c3tb20357c
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
We report Lipid OligoNucleotide conjugates (LONs) bearing either two or three hydrophobic chains. LONs self-assemble into micellar aggregates, which provide a suitable reservoir for hydrophobic drugs such as paclitaxel. Our results demonstrate that the composition of the LONs both in terms of the lipid and the oligonucleotide sequence impacts their ability to host lipophilic molecules. Interestingly, binding of the complementary oligonucleotide selectively induces the release of part of the drug payload of the aggregates. These LON based micelles, which efficiently host hydrophobic drugs, represent an original stimuli-responsive drug delivery system.
引用
收藏
页码:5329 / 5334
页数:6
相关论文
共 50 条
  • [21] Application of intelligent responsive DNA self-assembling nanomaterials in drug delivery
    Ji, Haofei
    Zhu, Qubo
    JOURNAL OF CONTROLLED RELEASE, 2023, 361 : 803 - 818
  • [22] Biodegradable and Stimuli-Responsive Nanomaterials for Targeted Drug Delivery in Autoimmune Diseases
    Parvin, Nargish
    Joo, Sang Woo
    Mandal, Tapas K.
    JOURNAL OF FUNCTIONAL BIOMATERIALS, 2025, 16 (01)
  • [23] Innovations in oligonucleotide drug delivery
    Lysik, MA
    Wu-Pong, S
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (08) : 1559 - 1573
  • [24] Advances in oligonucleotide drug delivery
    Roberts, Thomas C.
    Langer, Robert
    Wood, Matthew J. A.
    NATURE REVIEWS DRUG DISCOVERY, 2020, 19 (10) : 673 - 694
  • [25] Advances in oligonucleotide drug delivery
    Thomas C. Roberts
    Robert Langer
    Matthew J. A. Wood
    Nature Reviews Drug Discovery, 2020, 19 : 673 - 694
  • [26] Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
    Dugal-Tessier, Julien
    Thirumalairajan, Srinath
    Jain, Nareshkumar
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 17
  • [27] pH-responsive polymer-drug conjugates as multifunctional micelles for cancer-drug delivery
    Kang, Yang
    Ha, Wei
    Liu, Ying-Qian
    Ma, Yuan
    Fan, Min-Min
    Ding, Li-Sheng
    Zhang, Sheng
    Li, Bang-Jing
    NANOTECHNOLOGY, 2014, 25 (33)
  • [28] Stimuli-responsive phospholipid-drug conjugates (PDCs)-based nanovesicles for drug delivery and theranostics
    Yu, Jiang
    Liu, Ying
    Zhou, Shuang
    Wang, Yingli
    Wang, Yongjun
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 590
  • [29] Peptide-oligonucleotide conjugates for the delivery of antisense and siRNA
    Juliano, RL
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2005, 7 (02) : 132 - 136
  • [30] Tumor microenvironment stimuli-responsive lipid-drug conjugates for cancer treatment
    Husni, Patihul
    Lim, Chaemin
    Oh, Kyung Taek
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 639